Schwab Reports Monthly Activity Highlights
WESTLAKE, Texas–(BUSINESS WIRE)–The Charles Schwab Corporation released its Monthly Activity Report today. Company highlights for the month of January... Read more.
Trio-Tech Reports 82% Revenue Growth in Q2 FY2026, Reflecting Expanding Role in AI and EV Semiconductor Reliability Testing
VAN NUYS, Calif.–(BUSINESS WIRE)–Trio-Tech International (NYSE MKT: TRT), a comprehensive provider of semiconductor back-end solutions and a global value-added... Read more.
Mirion to Present at Citi’s 2026 Global Industrial Tech and Mobility Conference
ATLANTA–(BUSINESS WIRE)–Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical... Read more.
Granite Awarded Preconstruction Services Agreement for Progressive Design-Build Project on I-80 East in Nevada
WATSONVILLE, Calif.–(BUSINESS WIRE)–Granite (NYSE:GVA) today announced that the Nevada Department of Transportation (NDOT) has selected the company to... Read more.
Dell Technologies to Hold Conference Call Feb. 26 to Discuss Fourth Quarter and Full Fiscal 2026 Financial Results
ROUND ROCK, Texas–(BUSINESS WIRE)–Dell Technologies (NYSE: DELL) will conduct a conference call Thursday, Feb. 26, 2026, at 3:30 p.m. CST to discuss... Read more.
HUB Technical Services Named to CRN’s MSP 500 List For 2026
SOUTH EASTON, Mass.–(BUSINESS WIRE)–#CRNMSP500–HUB Technical Services, CONNECTED. MANAGED. SECURED., announced today that it has been named by... Read more.
MEDIPOST Inc. Submits IND Amendment With U.S. Food and Drug Administration to Initiate Phase III Trial
Submission marks key step in study of mesenchymal stem cell therapy to treat symptomatic cartilage defects in patients with knee osteoarthritis CAMBRIDGE, Mass.–(BUSINESS... Read more.
Cove Kaz Capital Group and Tau-Ken Samruk Execute Definitive Agreements to Develop the World’s Largest Known Undeveloped Tungsten Resource
ASTANA, Kazakhstan & NEW YORK–(BUSINESS WIRE)–Cove Kaz Capital Group (“Cove Kaz” or “the Company”), a portfolio company of Cove Capital LLC,... Read more.
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$anro #cns–Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company... Read more.
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
CHICAGO–(BUSINESS WIRE)–Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced... Read more.